Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,514,483
  • Shares Outstanding, K 31,611
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 154 M
  • EBITDA $ 321 M
  • 60-Month Beta 0.61
  • Price/Sales 2.37
  • Price/Cash Flow 3.84
  • Price/Book 5.44

Options Overview Details

View History
  • Implied Volatility 61.59% (+13.41%)
  • Historical Volatility 43.89%
  • IV Percentile 57%
  • IV Rank 58.33%
  • IV High 81.84% on 10/06/25
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 11) 1.06 (2.18%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 10
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 395
  • Open Int (30-Day) 2,225
  • Expected Range 47.61 to 49.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.03
  • Number of Estimates 3
  • High Estimate 2.08
  • Low Estimate 2.00
  • Prior Year 1.63
  • Growth Rate Est. (year over year) +24.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.98 +16.03%
on 11/10/25
49.04 -0.67%
on 12/08/25
+6.41 (+15.15%)
since 11/07/25
3-Month
31.26 +55.82%
on 10/13/25
49.04 -0.67%
on 12/08/25
+10.96 (+29.03%)
since 09/08/25
52-Week
23.23 +109.69%
on 04/10/25
49.04 -0.67%
on 12/08/25
+18.74 (+62.53%)
since 12/06/24

Most Recent Stories

More News
1 Mooning Stock with Promising Prospects and 2 Facing Challenges

1 Mooning Stock with Promising Prospects and 2 Facing Challenges

COLL : 47.91 (unch)
IRTC : 173.33 (-2.83%)
FBK : 56.87 (-0.04%)
1 Small-Cap Stock with Exciting Potential and 2 We Avoid

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

COLL : 47.91 (unch)
HIMS : 39.12 (-0.20%)
BOH : 67.41 (+1.35%)
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

COLL : 47.91 (unch)
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

COLL : 47.91 (unch)
VRTX : 442.04 (-2.95%)
ICFI : 82.49 (-3.02%)
Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies...

COLL : 47.91 (unch)
2 Momentum Stocks with Exciting Potential and 1 We Find Risky

2 Momentum Stocks with Exciting Potential and 1 We Find Risky

COLL : 47.91 (unch)
GMED : 89.00 (-2.31%)
NRDS : 15.13 (-1.94%)
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook

COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook

COLL : 47.91 (unch)
Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

COLL : 47.91 (unch)
Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%

Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%

COLL : 47.91 (unch)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 47.91 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 49.39
2nd Resistance Point 48.66
1st Resistance Point 48.28
Last Price 47.91
1st Support Level 47.17
2nd Support Level 46.44
3rd Support Level 46.06

See More

52-Week High 49.04
Last Price 47.91
Fibonacci 61.8% 39.18
Fibonacci 50% 36.14
Fibonacci 38.2% 33.09
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar